WIRED Science on Nostr: Supplements Companies Are Cashing In on the Ozempic Wave With demand for GLP-1 drugs ...
Published at
2024-08-14 11:30:14Event JSON
{
"id": "cdfcbc9769ccd4bca5de276132472d877c5c4fb6655eb5de3152cd36417887a2",
"pubkey": "111cd02902d3e849b9cf3879efafdfd4587d8b51b42215d9bee8c78160796480",
"created_at": 1723635014,
"kind": 1,
"tags": [
[
"guid",
"6669bedf77fcdbbfd5d5b615"
]
],
"content": "Supplements Companies Are Cashing In on the Ozempic Wave\n\nhttps://media.wired.com/photos/66a100aeebac93f578ba8d0a/master/pass/072424_GLP-1%20Series%2004%20Supplements%20Grifters.jpg\n\nWith demand for GLP-1 drugs sky-high, the supplement industry is elbowing into the market. Some products are meant to complement meds like Ozempic. Others are positioned as “natural” alternatives.\n\nhttps://www.wired.com/story/the-ozempic-adjacent-supplement-gold-rush-is-just-getting-started/",
"sig": "e86d9a690b2cdf4807b4ccd503a05a0593d9ea571b810b0adb811eb2cfb1e2ec9b7498eae22b7768a62d56c88077e33d23d6209a80f58c273c2be2d217a5415c"
}
